To read and or download the pdf articles click on the links below.

• Missouri State University Press Release “Study Evaluates Treatment of “Long COVID” Patients – N115 shows promise on debilitating symptoms
  

  ---

• Inhalation of Sodium Pyruvate to Reduce the Symptoms and Severity of Respiratory Diseases Including COVID-19, Long COVID, and Pulmonary Fibrosis 11-02-21
  

  ---

• EMPHYCORP INFLUENZA AND COVID-19 ANIMAL AND HUMAN STUDIES 11-02-21
  

  ---

• New Non-Steroidal Treatment for Pulmonary Fibrosis (IPF) to improve Patient Quality of Life 11-02-21
  

  ---

• Sodium Pyruvate Nasal Spray Studies: Safety and Efficacy Data submitted to the FDA 11-02-21
  

  ---

• N115 FDA SUBMISSIONS 11-02-21
  

  ---

• Evaluation of the Sodium Pyruvate Formulation to Deliver Other Drugs 11-02-21